Skip to main content
SpringerLink
Log in

Drug hydroxylator phenotype in Hungary

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Idle JR, Smith RL (1979) Polymorphism of oxidation at carbon centers of drugs and their clinical sigificance. Drug Metab Rev 9: 301–317

    Google Scholar 

  2. Kalow W (1982) Ethnic differences in drug metabolism. Clin Pharmacokinet 7: 373–400

    Google Scholar 

  3. Kalow W (1985) Pharmacoanthropology. Ann Biol Clin 43: 519–534

    Google Scholar 

  4. Lennard MS, Silas JH, Smith AJ, Tucker GT (1977) Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection. J Chromatogr 133: 161–166

    Google Scholar 

  5. Smith RL (1980) A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet 17: 102–105

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children's Hospital, Szeged, Hungary

    I. Szórády & A. Sánta

Authors
  1. I. Szórády
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Sánta
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szórády, I., Sánta, A. Drug hydroxylator phenotype in Hungary. Eur J Clin Pharmacol 32, 325 (1987). https://doi.org/10.1007/BF00607584

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00607584

Key words

Search

Navigation